Gold prices steady ahead of Fed decision, Trump’s tariff deadline
BOSTON - PureTech Health plc (NASDAQ:PRTC, LSE:PRTC), a company engaged in the development of biotherapeutics for severe diseases, is scheduled to participate in a fireside chat at the upcoming Jefferies Global Healthcare Conference. The event will take place on Thursday, June 5, 2025, featuring CEO Bharatt Chowrira and President Eric Elenko.
The presentation by PureTech’s executives is set for 10:30 am EDT and will be accessible via webcast. This engagement offers the company an opportunity to discuss its clinical-stage projects and share insights into its strategic direction and advancements.
PureTech’s portfolio includes 29 therapeutics and therapeutic candidates, with three already receiving FDA approval. The company’s R&D efforts are propelled by a network of scientists, clinicians, and industry experts, with a focus on both internal advancement and development through its Founded Entities.
The press release includes cautionary statements about forward-looking information, reminding readers of the risks and uncertainties that could affect the company’s actual results and performance. PureTech’s forward-looking statements rely on assumptions about its present and future business strategies and the operational environment.
The information presented in this article is based on a press release statement from PureTech Health.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.